Folgen
Gemma Navarro
Gemma Navarro
Full-professor of Pharmacy
Bestätigte E-Mail-Adresse bei ub.edu
Titel
Zitiert von
Zitiert von
Jahr
Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli
J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ...
Archives of internal medicine 168 (17), 1897-1902, 2008
5692008
Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis
J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Pena, ...
Clinical infectious diseases 50 (1), 40-48, 2010
4612010
Detection of heteromerization of more than two proteins by sequential BRET-FRET
P Carriba, G Navarro, F Ciruela, S Ferré, V Casadó, L Agnati, A Cortés, ...
Nature methods 5 (8), 727-733, 2008
3532008
Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
J Rodríguez-Bano, E Picón, P Gijón, JR Hernández, JM Cisneros, C Pena, ...
Journal of clinical microbiology 48 (5), 1726-1731, 2010
2312010
Validation of the Spanish version of the Lawton IADL Scale for its application in elderly people
I Vergara, A Bilbao, M Orive, S Garcia-Gutierrez, G Navarro, JM Quintana
Health and quality of life outcomes 10, 1-7, 2012
2202012
The Minnesota living with heart failure questionnaire: comparison of different factor structures
A Bilbao, A Escobar, L García-Perez, G Navarro, R Quirós
Health and quality of life outcomes 14, 1-11, 2016
2182016
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors
X Viñals, E Moreno, L Lanfumey, A Cordomí, A Pastor, R de La Torre, ...
PLoS biology 13 (7), e1002194, 2015
2102015
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors
E Martínez-Pinilla, K Varani, I Reyes-Resina, E Angelats, F Vincenzi, ...
Frontiers in pharmacology 8, 290777, 2017
1852017
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
G Navarro, E Moreno, M Aymerich, D Marcellino, PJ McCormick, J Mallol, ...
Proceedings of the National Academy of Sciences 107 (43), 18676-18681, 2010
1852010
Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer
J Bonaventura, G Navarro, V Casadó-Anguera, K Azdad, W Rea, ...
Proceedings of the National Academy of Sciences 112 (27), E3609-E3618, 2015
1642015
Adenosine–cannabinoid receptor interactions. Implications for striatal function
S Ferré, C Lluís, Z Justinova, C Quiroz, M Orru, G Navarro, EI Canela, ...
British journal of pharmacology 160 (3), 443-453, 2010
1612010
Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or more
MM Nogueras, G Navarro, E Antón, M Sala, M Cervantes, MJ Amengual, ...
BMC infectious diseases 6, 1-9, 2006
1592006
Detection of Heteromers Formed by Cannabinoid CB1, Dopamine D2, and Adenosine A2A G-Protein-Coupled Receptors by Combining Bimolecular …
G Navarro, P Carriba, J Gandí, F Ciruela, V Casadó, A Cortés, J Mallol, ...
The Scientific World Journal 8, 1088-1097, 2008
1562008
A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
S Cristóvão-Ferreira, G Navarro, M Brugarolas, K Pérez-Capote, SH Vaz, ...
Purinergic signalling 9, 433-449, 2013
1512013
Basic pharmacological and structural evidence for class A G-protein-coupled receptor heteromerization
R Franco, E Martínez-Pinilla, JL Lanciego, G Navarro
Frontiers in pharmacology 7, 181687, 2016
1482016
Targeting cannabinoid CB2 receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders
G Navarro, P Morales, C Rodríguez-Cueto, J Fernández-Ruiz, ...
Frontiers in Neuroscience 10, 211100, 2016
1462016
Cocaine Inhibits Dopamine D2 Receptor Signaling via Sigma-1-D2 Receptor Heteromers
G Navarro, E Moreno, J Bonaventura, M Brugarolas, D Farre, D Aguinaga, ...
PloS one 8 (4), e61245, 2013
1422013
Functional selectivity of allosteric interactions within G protein–coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer
X Guitart, G Navarro, E Moreno, H Yano, NS Cai, M Sánchez-Soto, ...
Molecular pharmacology 86 (4), 417-429, 2014
1382014
Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway
E Moreno, H Hoffmann, M Gonzalez-Sepulveda, G Navarro, V Casado, ...
Journal of biological chemistry 286 (7), 5846-5854, 2011
1362011
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1–CB2 heteroreceptor complexes
G Navarro, K Varani, I Reyes-Resina, V Sánchez de Medina, ...
Frontiers in pharmacology 9, 366412, 2018
1312018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20